News and research.

NewsAugust 27, 2020

SubjectWell eyes diversity in COVID-19 vaccine trials

Outsourcing-Pharma.com
Press ReleaseAugust 25, 2020

SubjectWell Recruits Patients for COVID-19 Vaccine Clinical Trials, Works to Address Lack of Racial Diversity in Patient Recruitment To Date

Austin, TX, August 25, 2020 – SubjectWell, the largest risk-free clinical trials marketplace, announced today it is working with leading pharmaceutical companies to recruit patients for Phase...
ResearchJuly 21, 2020

Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic.

At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of...
NewsJune 16, 2020

Registry connects COVID-19 trials with motivated patients

Outsourcing-Pharma.com
ResearchMay 28, 2020

Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic.

At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been...
Press ReleaseMay 13, 2020

SubjectWell Offers Researchers Registry of 10K+ Patients Willing to Participate in COVID-19 Research

Austin, TX, May 13, 2020 – As the pharmaceutical industry mobilizes at unprecedented speed to develop a COVID-19 vaccine, SubjectWell, the world’s largest marketplace for clinical...
ResearchApril 17, 2020

A growing number of patients are considering clinical trials as the coronavirus pandemic continues.

In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to...
NewsApril 14, 2020

Despite COVID-19, Patients Are Interested In New Trials

Clinical Leader
ResearchMarch 26, 2020

Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic.

The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our...